Evidence map›Paper›PMID 33568930›Full record

ReviewJournal of inflammation research2021

Overview on the Discovery and Development of Anti-Inflammatory Drugs: Should the Focus Be on Synthesis or Degradation of PGE

Gopa Mahesh, Kotha Anil Kumar, Pallu Reddanna

Open access · goldAbstract readReview
In one paragraph

Review in Journal of inflammation research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Virulence · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Regulatory Effect of PGEBiomolecules · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Imrecoxib: Advances in Pharmacology and Therapeutics.Drug design, development and therapy · 2024
    Review
  19. In vivo biological screening of extract and bioactive compound from Ficus benghalensis L. and their in silico molecular docking analysis.Technology and health care : official journal of the European Society for Engineering and Medicine · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gopa MaheshDepartment of Animal Biology, School of Life Sciences, University of Hyderabad, Hyderabad, 500046, India.
Kotha Anil KumarDepartment of Animal Biology, School of Life Sciences, University of Hyderabad, Hyderabad, 500046, India.
Pallu ReddannaDepartment of Animal Biology, School of Life Sciences, University of Hyderabad, Hyderabad, 500046, India.ORCID 0000-0001-6343-6758
University of Hyderabad · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is a protective response that develops against tissue injury and infection. Chronic inflammation, on the other hand, is the key player in the pathogenesis of many inflammatory disorders including cancer. The cytokine storm, an inflammatory response flaring out of control, is mostly responsible for the mortality in COVID-19 patients. Anti-inflammatory drugs inhibit cyclooxygenases (COX), which are involved in the biosynthesis of prostaglandins that promote inflammation. The conventional non-steroidal anti-inflammatory drugs (NSAIDs) are associated with gastric and renal side-effects, as they inhibit both the constitutive COX-1 and the inducible COX-2. The majority of selective COX-2 inhibitors (COXIBs) are without gastric side-effects but are associated with cardiac side-effects on long-term use. The search for anti-inflammatory drugs without side-effects, therefore, has become a dream and ongoing effort of the Pharma companies. As PGE

Indexed as

15-hydroxy prostaglandin dehydrogenase15-PGDH5-lipoxygenase5-LOXCOXCOXIBscyclooxygenaseinflammationmicrosomal PGE synthase-1mPGES-1NSAIDs

Identifiers

PMID33568930
PMCPMC7868279
OpenAlexW3129006906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.